Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 1,320

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency

Open access
Farooqi, I. Sadaf, Matarese, Giuseppe, Lord, Graham M., Keogh, Julia M., Lawrence, Elizabeth, Agwu, Chizo, Sanna, Veronica, Jebb, Susan A., Perna, Francesco, Fontana, Silvia, Lechler, Robert I., DePaoli, Alex M., O’Rahilly, Stephen·2002·Journal of Clinical Investigation

Abstract

The wide range of phenotypic abnormalities seen in the leptin-deficient ob/ob mouse and their reversibility by leptin administration provide compelling evidence for the existence of multiple physiological functions of this hormone in rodents. In contrast, information regarding the roles of this hormone in humans is limited. Three morbidly obese children, who were congenitally deficient in leptin, were treated with daily subcutaneous injections of recombinant human leptin for up to 4 years with sustained, beneficial effects on appetite, fat mass, hyperinsulinemia, and hyperlipidemia. Leptin therapy resulted in a rapid and sustained increase in plasma thyroid hormone levels and, through its age-dependent effects on gonadotropin secretion, facilitated appropriately timed pubertal development. Leptin deficiency was associated with reduced numbers of circulating CD4(+) T cells and impaired T cell proliferation and cytokine release, all of which were reversed by recombinant human leptin administration. The subcutaneous administration of recombinant human leptin has major and sustained beneficial effects on the multiple phenotypic abnormalities associated with congenital human leptin deficiency.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci15693

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 31

  1. Swerdloff, 1976, Endocrinology, 98, 1359, 10.1210/endo-98-6-1359 · DOI · Paper page
  2. Dubuc, 1977, Horm Metab Res, 9, 95, 10.1055/s-0028-1095550 · DOI
  3. 10.1038/266060a0 · DOI · Paper page
  4. Ohtake, 1977, Am J Physiol, 233, 110
  5. Bray, 1971, Physiol Rev, 51, 598, 10.1152/physrev.1971.51.3.598 · DOI · Paper page
  6. 10.1038/29795 · DOI · Paper page
  7. 10.1126/science.7624777 · DOI · Paper page
  8. 10.1126/science.7624776 · DOI · Paper page
  9. 10.1038/ng0396-318 · DOI · Paper page
  10. 10.1210/en.137.7.3144 · doi:10.1210/en.137.7.3144 · Paper page
  11. 10.1038/43185 · DOI · Paper page
  12. 10.1079/BJN19970021 · DOI
  13. Murgatroyd, 1993, Int J Obes Relat Metab Disord, 17, 549
  14. Fomon, 1982, Am J Clin Nutr, 35, 1169, 10.1093/ajcn/35.5.1169 · DOI · Paper page
  15. Hamill, 1979, Am J Clin Nutr, 32, 607, 10.1093/ajcn/32.3.607 · DOI · Paper page
  16. Matarese, 2001, J Immunol, 166, 5909, 10.4049/jimmunol.166.10.5909 · DOI · Paper page
  17. 10.1001/jama.282.16.1568 · DOI · Paper page
  18. 10.2337/diabetes.47.4.538 · DOI
  19. Franssila-Kallunki, 1992, Am J Clin Nutr, 56(Suppl.), 247S, 10.1093/ajcn/56.1.247S · DOI
  20. 10.1210/jc.85.4.1550 · DOI
  21. Weinsier, 2000, Am J Clin Nutr, 71, 1138, 10.1093/ajcn/71.5.1138 · DOI · Paper page
  22. 10.1210/en.140.8.3688 · DOI
  23. Havel, 2000, Proc Nutr Soc, 59, 69, 10.1017/S0029665100000410 · DOI · Paper page
  24. 10.1074/jbc.M003549200 · DOI · Paper page
  25. Dubuc, 1989, Horm Metab Res, 21, 546, 10.1055/s-2007-1009284 · DOI
  26. 10.1210/jc.84.10.3686 · doi:10.1210/jc.84.10.3686 · Paper page
  27. 10.1210/en.138.2.855 · doi:10.1210/en.138.2.855 · Paper page
  28. 10.1038/382250a0 · DOI · Paper page
  29. 10.1016/S1471-4906(02)02188-9 · DOI · Paper page
  30. 10.1172/JCI6762 · DOI · Paper page
  31. 10.1006/cimm.1999.1594 · DOI · Paper page

Cited by

See all 1,320

Metadata

Authors
Farooqi, I. S., Matarese, G., Lord, G. M., Keogh, J. M., Lawrence, E., Agwu, C., Sanna, V., Jebb, S. A., Perna, F., Fontana, S., Lechler, R. I., DePaoli, A. M., & O’Rahilly, S.
Venue
Journal of Clinical Investigation
Published
2002-10-15
Volume
110
Issue
8
Pages
1093-1103
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2098025594
Cited by
1,320
References
11
FWCI
16.97
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. https://app.cochat.ai/papers/10.1172/jci15693
The paper
Farooqi, I. S., Matarese, G., Lord, G. M., Keogh, J. M., Lawrence, E., Agwu, C., Sanna, V., Jebb, S. A., Perna, F., Fontana, S., Lechler, R. I., DePaoli, A. M., & O’Rahilly, S. (2002). Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. Journal of Clinical Investigation. https://doi.org/10.1172/jci15693

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.